PEB - Pacific Edge Ltd

[Ninefingers]

10s of thousands of tests!

[Schrodinger]

Good to see the USA grow but the cost of sales for the growth is unacceptable (not scaleable).

6-8 months cash left minus a quick cutback in expenditure. The next raise valuation will be interesting. Big question mark is on the slowdown in revenue and the key strategic question is to keep the under-performing sales team or trim R&D/sales team (OHE style).

Salvageable if they get realistic with their forecasts. I still cant see how this is worth $200M sub $100M (30c or less).

[Balance]

10s of thousands of tests!

Was supposed to happen in 2014 so only 3 years behind schedule.

As long as they get there before the next capital raise?

[JohnnyTheHorse]

Hope they still on track for that $100mil revenue after 5 years of US trading. Must be those transformational customers that'll get them there.

[winner69]

Hope they still on track for that $100mil revenue after 5 years of US trading. Must be those transformational customers that'll get them there.

At current running rate if they get to $100m sales bad debts will be $30m (conservatively)

[Schrodinger]

At current running rate if hey get to $100m sales bad debts will be $30m (conservatively)

So 1.5 years to get another $92M? Or stretch it out like WDT and use $200M cash to get $100 sales?

Balance or others....did you manage to find the test throughput for USA I want to know their average sales per test. I cant find it in the docs.

USA revenue is $7.8M.

[winner69]

The F16 accounts had this bit -

No allowance for bad debts have been recognised for the year ended 31 March 2016. Amounts overdue but not impaired are as follows:
- $2,398,052 is within 0 – 180 days old
- $967,510 is within 181 – 365 days old
- $882,046 is over 365 days old but is still expected to be recovered.

Total receivables were $4.8m at March 16 - $3.2m now written off - WTF - not really acceptable

Only sensible conclusion - most of all past sales were really 'free trials' as some have suggested on here (but invoiced in hope of being paid)

At least its a non cash expense this year PEB say - ha ha

[blackcap]

The F16 accounts had this bit -

No allowance for bad debts have been recognised for the year ended 31 March 2016. Amounts overdue but not impaired are as follows:
- $2,398,052 is within 0 – 180 days old
- $967,510 is within 181 – 365 days old
- $882,046 is over 365 days old but is still expected to be recovered.

Total receivables were $4.8m at March 16 - $3.2m now written off - WTF - not really acceptable

Only sensible conclusion - most of all past sales were really 'free trials' as some have suggested on here (but invoiced in hope of being paid)

At least its a non cash expense this year PEB say - ha ha

I noticed that bit. What is telling its not the usual 0-30 days, 30-60 days and 90+ days (pretty much write off) its that they go from 0- half year, half year to year and then the bit that's over 365 days but still expected to be recovered... that got the biggest smile from me.

[Balance]

T

Total receivables were $4.8m at March 16 - $3.2m now written off - WTF - not really acceptable

Only sensible conclusion - most of all past sales were really 'free trials' as some have suggested on here (but invoiced in hope of being paid)

At least its a non cash expense this year PEB say - ha ha

Egg all over the face of those in the company and the posters who chose to believe them that there were no 'free trials'.

That was actually so clear from the receivables level climbing year after year mirroring so called sales growth.

Biggest joke is that PEB had actually been paying royalties on those 'sales'!!!!!!!

[winner69]

Egg all over the face of those in the company and the posters who chose to believe them that there were no 'free trials'.

That was actually so clear from the receivables level climbing year after year mirroring so called sales growth.

Biggest joke is that PEB had actually been paying royalties on those 'sales'!!!!!!!

Auditors must have believed this transformational stuff